Watch Ticker

RAPT Therapeutics, Inc. Common Stock

Go to RAPT Therapeutics, Inc. Common Stock Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$148.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks

The heavy selling pressure might have exhausted for Rapt Therapeutics (RAPT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Related tickers: RAPT.

Read Full Article

RAPT Therapeutics, Inc. - RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

- Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status

Related tickers: RAPT.

Read Full Article

Trending Tickers

BTTX

XNAS

$0.00

(%)

OPRT

XNAS

$0.00

(%)

PALI

XNAS

$0.00

(%)

PRSO

XNAS

$0.00

(%)

ACRV

XNAS

$0.00

(%)